Gepsman Martin J's Form 4 filing
CME Group Inc. (CME) · filed Aug 30, 2021
- Accession no.
- 0001156375-21-000099
- Filed
- Aug 30, 2021
- Trade date
- Aug 30, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $201.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gepsman Martin JCIK 0001212813 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 | Common Stock Class A | SSaleDisposed | −100 | $201.03 | −$20,103 | 27,368 | Direct | |
| Aug 30, 2021 | Common Stock Class A | SSaleDisposed | −15 | $201.02 | −$3,015.3 | 27,353 | Direct | |
| Aug 30, 2021 | Common Stock Class A | SSaleDisposed | −885 | $201.00 | −$177,885 | 26,468 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.